Exercise moves the metabolic markers in PCOS

Polycystic ovary syndrome is often framed around reproductive symptoms, but it also travels with insulin resistance, unfavourable lipids and low-grade systemic inflammation, which is why cardiometabolic health matters in this group. Exercise is a standard recommendation, yet the impact on those specific markers has remained uncertain and the trials have used very different formats. Aerobic training, resistance training, combined programmes, high-intensity intervals and mind-body practices such as yoga and tai chi all appear in the literature. The practical question is not only whether exercise helps, but whether the choice of mode changes which marker improves.

The authors searched PubMed, Web of Science and Scopus from inception to July 2025 for randomised controlled trials in women with PCOS. Eligible trials compared aerobic training, resistance training, combined training, high-intensity interval training or yoga and tai chi against non-exercise controls or against another exercise mode, reporting markers of glucose homeostasis, lipid profiles or C-reactive protein. Both pairwise and network meta-analyses were performed, with weighted mean differences or standardised mean differences and 95% confidence intervals estimated using random-effects models. Twenty-five studies involving 1,107 participants with mean ages from 18 to 34 years were included.

Compared with controls, exercise training significantly reduced fasting insulin (SMD -0.28), HOMA-IR (SMD -0.50), triglycerides (-2.70 mg/dl), total cholesterol (-3.74 mg/dl) and CRP (SMD -0.61). No significant overall differences appeared for fasting glucose, LDL or HDL. The network analysis produced a mode-specific pattern: yoga or tai chi reduced fasting glucose (-5.54 mg/dL), aerobic training reduced HOMA-IR (SMD -0.57) and CRP (SMD -0.82), HIIT reduced fasting insulin (SMD -0.38), HOMA-IR (SMD -0.56) and LDL (-6.45 mg/dl), and combined training reduced triglycerides (-3.61 mg/dl) and LDL (-8.40 mg/dl), each versus controls.

This strengthens the case that exercise addresses the metabolic side of PCOS, not merely body weight, and extends earlier pairwise work by ranking modes against one another. The mode-specific pattern is intriguing but rests partly on indirect comparisons within a network, so the rankings are less secure than the overall pooled effects. The mismatch between a null overall fasting glucose result and a significant yoga or tai chi estimate illustrates how thin some individual nodes may be. Open questions include how long these changes persist, whether they track symptom relief, and how much of the effect depends on total training volume rather than mode.

If you have PCOS, this is a reason to think training can shift insulin and inflammation markers regardless of what the scales say. The markers that moved most were insulin, HOMA-IR and CRP, while fasting glucose, LDL and HDL did not change in the overall pooled result. The absolute lipid changes were modest, so this is not a substitute for medical management. The mode comparisons hint that different formats may favour different markers, but they are best read as a suggestion for further trials rather than a prescription.